Prostate-specific antigen elevated for several consecutive years need to be combined with the patient’s own, need to be further examined to clarify the cause of the disease, according to the cause of the choice of drugs, surgery and other methods of treatment.
If the consecutive examination is less than 4ng/ml, and the rate of elevation of prostate-specific antigen is less than 0.75ng/ml/year, then you can generally choose to continue to observe and dynamically review; if it is greater than 4ng/ml or 0.75ng/ml/year, you may need to consider the possibility of prostate cancer, and need to be further examined.
If prostate cancer is considered, magnetic resonance of the prostate, puncture biopsy and other tests can be carried out first. If prostate hyperplasia is finally diagnosed, oral finasteride and other medications can be chosen as the first treatment; if prostate cancer is diagnosed, patients with no metastases in the early stage can be chosen for surgical treatment, and patients with metastases can be considered to take bicalutamide and other medications to carry out endocrine therapy.
If abnormalities are found in the examination, please go to regular hospitals to consult specialists and follow their advice for examination and treatment, and the drugs should be applied under the guidance of doctors.